Joshua Bauml, MD

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses chimeric antigen receptor (CAR) T-cell therapy in head and neck cancer.

There could be a place for CAR T-cell therapy in head and neck cancer, says Bauml, but there are limitations.

Videos

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses CAR T-cell therapy in head and neck cancer.

Joshua Bauml, MD

Articles

Dr. Bauml on CAR T-Cell Therapy in Head and Neck Cancer